Drug factory · FDA FEI 3022837118
Hetero Labs Limited
Plot No. 28P1 to 36P1 and 37 to 54, Vemagal Industrial Area, Hobli Vemagal Kolar, India
No problems found at FDA's last inspection, Jan 31, 2025.
No Action Indicated: inspectors found no objectionable conditions.
1 drug inspection on record since 2025: 1 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|
| Acyclovir | Makes it |
Camber Pharmaceuticals Inc., Quallent Pharmaceuticals Health LLC |
31722-704, 31722-705, 82009-040 +1 |
| Eltrombopag | Makes it |
Camber Pharmaceuticals Inc., Quallent Pharmaceuticals Health LLC |
31722-841, 31722-842, 31722-843 +5 |
| Gabapentin | Makes it |
Camber Pharmaceuticals Inc. |
31722-148, 31722-149, 31722-150 |
| Hydralazine | Makes it |
Camber Pharmaceuticals Inc. |
31722-519, 31722-520, 31722-521 +1 |
| Levetiracetam | Makes it |
Camber Pharmaceuticals Inc., Northstar Rx LLC., Quallent Pharmaceuticals Health LLC |
31722-536, 31722-537, 31722-538 +9 |
| Rosuvastatin | Makes it |
Camber Pharmaceuticals Inc. |
31722-882, 31722-883, 31722-884 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|
| Jan 31, 2025 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: manufacture.